Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance?

By sjmartinez • June 21, 2023

Chester RC, Parikh RV. Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance? Circ Cardiovasc Interv. 2023 Jun;16(6):e013113. doi: 10.1161/CIRCINTERVENTIONS.123.013113. Epub 2023 Jun 20. PMID: 37339236.

Tags: angiography, Cardiology/Epi, coronary artery disease, drug-eluting stents, Editorials, percutaneous coronary intervention, Publications

Association of RSV Vaccination With Clinical Outcomes in Older Adults With Heart Failure: A Propensity-Matched Analysis

Khan A, Shabbir MR, Nasrallah J, Imtiaz M, Thyagaturu H, Fudim M, Mentz RJ, Fonarow GC. Association of RSV Vaccination With Clinical Outcomes in Older[...]

Trends in Guideline Directed Medical Therapy Use in Heart Failure With a Mildly Reduced Ejection Fraction

Girard AA, Martinez OC, Ikeaba U, Jawad MA, Ikemura N, Chiswell K, Greene SJ, Fonarow GC, Chan PS, Sauer AJ, Spertus JA. Trends in Guideline[...]

Coronary Artery Calcium in ACC/AHA Prevention Guidelines: Evolution From 2007 to 2026

Irannejad K, Mora R, Krishnan S, Lakshmanan S, Roy S, Budoff MJ. Coronary Artery Calcium in ACC/AHA Prevention Guidelines: Evolution From 2007 to 2026. JACC[...]